Anxiolytic Effects of Gly-His-Lys Peptide and Its Analogs
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605537631 | ||
| 003 | CHVBK | ||
| 005 | 20210128100858.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150401xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2847-3 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2847-3 | ||
| 245 | 0 | 0 | |a Anxiolytic Effects of Gly-His-Lys Peptide and Its Analogs |h [Elektronische Daten] |c [I. Bobyntsev, O. Chernysheva, M. Dolgintsev, M. Smakhtin, A. Belykh] |
| 520 | 3 | |a Intraperitoneal administration of tripeptide Gly-His-Lys to male rats in doses of 0.5, 5, and 50 μg/kg 12 min before the start of the experiment produced an anxiolytic effect in the elevated plus maze test manifested in an increase in the time spent in open arms and shortened time spent in the closed arms. The anxiolytic effect was most pronounced after injection of 0.5 μg/kg peptide and decreased with increasing the dose of the peptide. Replacement of L-lysine with D-lysine in the tripeptide molecule was accompanied by a significant weakening of the neurotropic effects in all studied doses. Attachment of D-alanine to N- or C-terminus of Gly-His-Lys peptide leveled its anxiolytic action in all doses; significant changes in some measures of increased anxiety after administration at 50 μg/kg were found. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a regulatory peptides |2 nationallicence | |
| 690 | 7 | |a anxiolytic effect |2 nationallicence | |
| 690 | 7 | |a anxiety |2 nationallicence | |
| 690 | 7 | |a behavior |2 nationallicence | |
| 700 | 1 | |a Bobyntsev |D I. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | |
| 700 | 1 | |a Chernysheva |D O. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | |
| 700 | 1 | |a Dolgintsev |D M. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | |
| 700 | 1 | |a Smakhtin |D M. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | |
| 700 | 1 | |a Belykh |D A. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/6(2015-04-01), 726-728 |x 0007-4888 |q 158:6<726 |1 2015 |2 158 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2847-3 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2847-3 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bobyntsev |D I. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Chernysheva |D O. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Dolgintsev |D M. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Smakhtin |D M. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Belykh |D A. |u Department of Pathophysiology, Kursk State Medical University, Kursk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/6(2015-04-01), 726-728 |x 0007-4888 |q 158:6<726 |1 2015 |2 158 |o 10517 | ||